Helena Jernström

9PUBLICATIONS
88CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersBehavioural epidemiologyMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 13, 2025
Threshold-Based Overlap of Breast Cancer High-Risk Classification Using Family History, Polygenic Risk Scores, and Traditional Risk Models in 180,398 Women.

Peh Joo Ho, Christine Kim Yan Loo, Ryan Jak Yang Lim

|Jul 29, 2025
Prognostic Differences of Adjuvant Radiotherapy in Breast Cancer Cohorts Based on <i>PRLR</i> Genotypes, Expression, and Transcriptional Network Regulation.

Floor Munnik, Kelin Gonçalves de Oliveira, Christopher Godina

|Jul 11, 2025
Interplay between AHR genotypes, lifestyle factors and adjuvant breast cancer treatments significantly impacts clinical outcome in a population-based cohort.

Annelie Augustinsson, Christopher Godina, Linn Nilsson

|Apr 15, 2025
Genetic determinants and clinical significance of circulating and tumor-specific levels of insulin-like growth factor binding protein 7 (IGFBP7) in a Swedish breast cancer cohort.

Christopher Godina, Ann H Rosendahl, Kelin Gonçalves de Oliveira

|Oct 03, 2024
Targeting IGF-IR improves neoadjuvant chemotherapy efficacy in breast cancers with low IGFBP7 expression.

Christopher Godina, Michael N Pollak, Helena Jernström

|Apr 13, 2024
The Vitamin D Receptor as a Prognostic Marker in Breast Cancer-A Cohort Study.

Linnea Huss, Igis Gulz-Haake, Emma Nilsson

Pageof 2

Frequent Collaborators

3 joint publications

Christopher Godina

3 joint publications

Kelin Gonçalves de Oliveira

2 joint publications

Thilo Dörk

2 joint publications

Maartje J Hooning